 |
 |

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease
The Framingham Heart Study
Ernst J. Schaefer, MD;
Vanina Bongard, MD, PhD;
Alexa S. Beiser, PhD;
Stefania Lamon-Fava, MD, PhD;
Sander J. Robins, MD;
Rhoda Au, PhD;
Katherine L. Tucker, PhD;
David J. Kyle, PhD;
Peter W. F. Wilson, MD;
Philip A. Wolf, MD
Arch Neurol. 2006;63:1545-1550.
Background Docosahexaenoic acid (DHA) is an abundant fatty acid in the brain. In the diet, DHA is found mostly in fatty fish. The content of DHA has been shown to be decreased in the brain and plasma of patients with dementia.
Objective To determine whether plasma phosphatidylcholine (PC) DHA content is associated with the risk of developing dementia.
Design, Setting, and Participants A prospective follow-up study in 899 men and women who were free of dementia at baseline, had a median age of 76.0 years, and were followed up for a mean of 9.1 years for the development of all-cause dementia and Alzheimer disease.
Main Outcome Measures Plasma PC fatty acid levels were measured at baseline. Cox proportional regression analysis was used to assess relative risks of all-cause dementia and Alzheimer disease according to baseline plasma levels.
Results Ninety-nine new cases of dementia (including 71 of Alzheimer disease) occurred during the follow-up. After adjustment for age, sex, apolipoprotein E 4 allele, plasma homocysteine concentration, and education level, subjects in the upper quartile of baseline plasma PC DHA levels, compared with subjects in the lower 3 quartiles, had a relative risk of 0.53 of developing all-cause dementia (95% confidence interval, 0.29-0.97; P=.04) and 0.61 of developing Alzheimer disease (95% confidence interval, 0.31-1.18; P=.14). Subjects in the upper quartile of plasma PC DHA levels had a mean DHA intake of 0.18 g/d and a mean fish intake of 3.0 servings per week (P<.001) in a subset of 488 participants. We found no other significant associations.
Conclusion The top quartile of plasma PC DHA level was associated with a significant 47% reduction in the risk of developing all-cause dementia in the Framingham Heart Study.
Author Affiliations: Lipid Metabolism Laboratory (Drs Schaefer, Bongard, and Lamon-Fava) and Dietary Assessment and Epidemiology Program (Dr Tucker), Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Department of Biostatistics, Boston University School of Public Health (Dr Beiser), and Department of Endocrinology, Nutrition, and Diabetes (Dr Robins) and Department of Neurology (Drs Au and Wolf), Boston University School of Medicine, Boston, Mass; Martek Biosciences Corporation, Columbia, Md (Dr Kyle); and Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass (Drs Wilson and Wolf).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Docosahexaenoic Acid and Alzheimer Disease
Martha Clare Morris
Arch Neurol. 2006;63(11):1527-1528.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Whole-body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in unanesthetized rats
Gao et al.
J. Lipid Res. 2009;50:2463-2470.
ABSTRACT
| FULL TEXT
Dietary Arachidonic Acid to EPA and DHA Balance Is Increased among Canadian Pregnant Women with Low Fish Intake
Friesen and Innis
J. Nutr. 2009;139:2344-2350.
ABSTRACT
| FULL TEXT
Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging
Kroger et al.
Am. J. Clin. Nutr. 2009;90:184-192.
ABSTRACT
| FULL TEXT
Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk
Devore et al.
Am. J. Clin. Nutr. 2009;90:170-176.
ABSTRACT
| FULL TEXT
Omega-3 Fatty Acids in Metabolism, Health, and Nutrition and for Modified Animal Product Foods
Palmquist
Professional Animal Scientist 2009;25:207-249.
ABSTRACT
Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids
Harris et al.
J. Nutr. 2009;139:804S-819S.
ABSTRACT
| FULL TEXT
Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study
Park et al.
Am. J. Clin. Nutr. 2009;89:778-786.
ABSTRACT
| FULL TEXT
Omega-3 fatty acids: a comprehensive review of their role in health and disease
Yashodhara et al.
Postgrad. Med. J. 2009;85:84-90.
ABSTRACT
| FULL TEXT
A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
Fourcade et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E211-E221.
ABSTRACT
| FULL TEXT
Dementia Prevention: Methodological Explanations for Inconsistent Results
Coley et al.
Epidemiol Rev 2008;30:35-66.
ABSTRACT
| FULL TEXT
Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk
Samieri et al.
Am. J. Clin. Nutr. 2008;88:714-721.
ABSTRACT
| FULL TEXT
Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial
van de Rest et al.
Neurology 2008;71:430-438.
ABSTRACT
| FULL TEXT
Electrophilic Cyclopentenone Neuroprostanes Are Anti-inflammatory Mediators Formed from the Peroxidation of the {omega}-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid
Musiek et al.
J. Biol. Chem. 2008;283:19927-19935.
ABSTRACT
| FULL TEXT
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
Bousquet et al.
FASEB J. 2008;22:1213-1225.
ABSTRACT
| FULL TEXT
Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants
Innis and Friesen
Am. J. Clin. Nutr. 2008;87:548-557.
ABSTRACT
| FULL TEXT
Dietary Polyunsaturated Fat that Is Low in (n-3) and High in (n-6) Fatty Acids Alters the SNARE Protein Complex and Nitrosylation in Rat Hippocampus
Pongrac et al.
J. Nutr. 2007;137:1852-1856.
ABSTRACT
| FULL TEXT
Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-{beta} and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
Green et al.
J. Neurosci. 2007;27:4385-4395.
ABSTRACT
| FULL TEXT
The importance of fish and docosahexaenoic acid in Alzheimer disease
Connor and Connor
Am. J. Clin. Nutr. 2007;85:929-930.
FULL TEXT
Relationship of vascular risk to the progression of Alzheimer disease
Borroni et al.
Neurology 2007;68:1083-1084.
FULL TEXT
Docosahexaenoic Acid and Alzheimer Disease
Morris
Arch Neurol 2006;63:1527-1528.
FULL TEXT
|